OTTAWA, June 7, 2011 /CNW/ - Juvenile Diabetes Research Foundation
(JDRF) applauds the Government of Canada for reaffirming its commitment
to research and innovation.
As the leader in setting the agenda for type 1 diabetes research
worldwide, and as the largest charitable funder and advocate of type 1
diabetes research, JDRF knows firsthand that partnership with
government, academia and industry increases the value of research
In 2009, JDRF and the Government of Canada launched a $33.9 million
partnership to establish a Canadian Clinical Trial Network (CCTN) to
accelerate research advances for type 1 diabetes and its complications.
"The budget recognizes the critical role cutting-edge research and
innovation plays in increasing both economic competitiveness and
productivity," said Andrew McKee, President and CEO of JDRF Canada.
The budget includes a number of measures for Canada's research community
$65 million for Genome Canada to continue its revolutionary work in
genomics and proteomics;
$53.5 million over five years to support 10 new Canada Excellence
$100 million to help establish a Canada Brain Research Fund;
$50 million over five years beginning in 2012-2013 to support the
Perimeter Institute for Theoretical Physics; and
Ongoing support for Canada's three federal research granting councils.
"As a partner of the government's first partnership to benefit the
diabetes and diabetes research community, JDRF is pleased to see that
the Government of Canada continues to support partnerships between
private and public sectors which promote cutting-edge research,
innovation and commercialization," said McKee.
JDRF is the leading charitable funder and advocate of type 1 diabetes
research worldwide. JDRF's mission is to find a cure for diabetes and
its complications through the support of research. JDRF funding and
leadership is associated with most major scientific breakthroughs in
type 1 diabetes research to date in Canada and around the world. It has
raised more than $1.5 billion for diabetes research since its inception
in 1970, including $107 million in 2010. JDRF raises funds in 7
countries, and is funding research in 19, including over 50 human
clinical trials. Over 80 per cent of the funds JDRF expends support
research and research related education. For more information, please
The CCTN is a groundbreaking effort to accelerate made-in-Canada
solutions for the management, care and cure of diabetes. The CCTN is
currently developing several high-profile clinical trials, in
association with leading diabetes researchers at partner universities
and medical centers in Southern Ontario. The goal is to position
Southern Ontario as an international hub for diabetes translational
research, innovation, and commercialization of new therapeutics and
enabling technologies and expand throughout Canada in the coming
months. For more information, please visit www.cctn.jdrf.ca.
SOURCE Juvenile Diabetes Research Foundation
For further information:
Jennifer Dent, JDRF